GGrantIndex
← Leaderboards

Timothy Gershon

Univ Of North Carolina Chapel Hill

$5,878,276
Attributed
$5,878,276
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY201223
$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$5,878,276 · 4

By mechanism

R01$5,173,501 · 3
K08$704,775 · 1

Top collaborators

No co-investigators on record.

Most similar at Univ Of North Carolina Chapel Hill

Same institution · by research overlap

Others in their field

Top investigators on “Apoptosis

Research focus

ApoptosisMedulloblastomaProliferatingTumor GrowthIn VivoMediatingMalignant Neoplasm Of BrainLinkTumorNeurogenesisNerve Stem CellPathogenesisPostnatalRegulationBrainGrowthInsightCerebellumCytoplasmic GranulesBaseProgenitorPreventResponseGenetic

Grant awards (21)

Defining the crucial role of MAGOH in cerebellar development and the potential for targeting the EJC in medulloblastoma treatment$342,344
R01 · FY2023 · NS · contact PI
Bcl-xL-regulated apoptosis in cerebellar development and medulloblastoma treatment$243,251
R01 · FY2022 · NS · contact PI
Bcl-xL-regulated apoptosis in cerebellar development and medulloblastoma treatment$95,418
R01 · FY2022 · NS · contact PI
Bcl-xL-regulated apoptosis in cerebellar development and medulloblastoma treatment$338,617
R01 · FY2021 · NS · contact PI
Defining the crucial role of MAGOH in cerebellar development and the potential for targeting the EJC in medulloblastoma treatment$336,535
R01 · FY2021 · NS · contact PI
Bcl-xL-regulated apoptosis in cerebellar development and medulloblastoma treatment$408,894
R01 · FY2020 · NS · contact PI
Defining the crucial role of MAGOH in cerebellar development and the potential for targeting the EJC in medulloblastoma treatment$336,535
R01 · FY2020 · NS · contact PI
Bcl-xL-regulated apoptosis in cerebellar development and medulloblastoma treatment$338,617
R01 · FY2019 · NS · contact PI
Defining the crucial role of MAGOH in cerebellar development and the potential for targeting the EJC in medulloblastoma treatment$336,535
R01 · FY2019 · NS · contact PI
Glycolytic regulation of cerebellar development and medulloblastoma tumorigenesis$327,837
R01 · FY2019 · NS · contact PI
Bcl-xL-regulated apoptosis in cerebellar development and medulloblastoma treatment$70,277
R01 · FY2019 · NS · contact PI
Bcl-xL-regulated apoptosis in cerebellar development and medulloblastoma treatment$350,758
R01 · FY2018 · NS · contact PI
Defining the crucial role of MAGOH in cerebellar development and the potential for targeting the EJC in medulloblastoma treatment$336,535
R01 · FY2018 · NS · contact PI
Glycolytic regulation of cerebellar development and medulloblastoma tumorigenesis$327,837
R01 · FY2018 · NS · contact PI
Glycolytic regulation of cerebellar development and medulloblastoma tumorigenesis$327,837
R01 · FY2017 · NS · contact PI
Glycolytic regulation of cerebellar development and medulloblastoma tumorigenesis$327,837
R01 · FY2016 · NS · contact PI
Glycolytic regulation of cerebellar development and medulloblastoma tumorigenesis$327,837
R01 · FY2015 · NS · contact PI
Aerobic glycolysis regulates apoptosis in neurogenesis and medulloblastoma$176,618
K08 · FY2015 · NS · contact PI
Aerobic glycolysis regulates apoptosis in neurogenesis and medulloblastoma$176,618
K08 · FY2014 · NS · contact PI
Aerobic glycolysis regulates apoptosis in neurogenesis and medulloblastoma$176,618
K08 · FY2013 · NS · contact PI
Aerobic glycolysis regulates apoptosis in neurogenesis and medulloblastoma$174,921
K08 · FY2012 · NS · contact PI